Welcome letter
Dr. Mohamed Babiker
President of MENA Congress for Neurogenetic Disorders 2025
Consultant Pediatric Neurology and Director of Pediatric Neurology Residency Program, Al Jalila Children`s Specialty Hospital
Clinical Associate Professor, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE
A very warm welcome to the 2nd MENA Congress for Neurogenetic Disorders.
It is with great pleasure that we invite you all to this one-of-a-kind conference in the region in its second edition building on the success of the first conference last year. The 1st MENA Congress for Neurogenic Disorders 2024 which was held on 15-16 November 2024 in Dubai, UAE, was the first regional conference that is fully detected to neurogenetic disorders. The first edition was very successful with 35 speakers, including 7 international experts, and more than 200 participants with more than 30% coming from other countries. Variable topics related to neurogenetics were discussed with 95% of attendees giving an above-average evaluation for the presentations.
The 2nd MENA Congress for Neurogenetic Disorders 2025 will take place on 17-18 October 2025 and will include experts, researchers, clinicians, and professionals from across the region and beyond gather here in Dubai to exchange knowledge, discuss advancements, and collaborate in the field of genetically-determined neurological disorders manifesting across the life span. This conference serves as a platform whereby clinical experiences are shared, basics but also emerging trends are tapped into whilst we collaborate towards better outcomes for our patients.
Throughout the event, we will hear from esteemed experts, engage in thought-provoking discussions, and explore innovative approaches to diagnosis, treatment, and management of neurogenetic disorders.
Let's join hands to make a positive impact on the lives of children and adults with neurogenetic disorders and that of their families too.
ABSTRACT SUBMISSION
Abstract submission for the 2nd MENA Congress for Neurogenetic Disorders 2025 is open. Researchers, physicians, residents, students, and all delegates are invited to submit their abstracts.
Topics must be relevant to the field of neurogenetic disorders in one, or more, of these areas: neuromuscular diseases, neurodegenerative diseases, neurometabolic diseases, genetic epilepsies, neurodevelopmental disorders, and movement disorders.
- Abstract submission is through the congress website: https://neurogenetics.ae/
- Abstract submission deadline is 31 August 2025.
- The accepted abstracts will be presented as posters, and the top 3 abstracts will be selected for oral presentations. Abstract submitters will be notified whether abstract has been selected for poster or oral presentation by 15 September 2025.
- During the congress, 3 posters will be selected and recognized as the best posters.
The following sections need to be filled: submitter email address, abstract authors, abstract title, and abstract body.
Abstract body should not exceed 250 words.
Abstract body needs to be organized as following: Objective (or Introduction), Methods, Results, Conclusions, Acknowledgements and/or Disclosures (if appropriate). Tables, figures or references should not be included.
The presenter of the poster or the oral presentation must be one of the submitting author and must be registered for attendance at the conference.
Pharmaceutical companies are permitted to submit abstracts that contain their own data, but the presenting author must be a doctor or an allied health professional currently practicing clinically in neurology or other related disciplines and must be one of the abstract authors.
For abstracts accepted for poster presentation, further information regarding poster specifications will be provided.
For the abstracts selected for oral presentations, further information regarding oral presentation specifications will be provided.
TOPICS COVERED
Genetics epilepsies
Neurodegenerative and white matter disorders
Movement disorders
Neurometabolic diseases
Neurodevelopmental disorders
Neuromuscular diseases
Updates on diagnostics
Advancements in therapeutics
PARTICIPANTS
Medical doctors from variable specialties and dentists
Nurses, dietitians, therapists, and genetic counselors
Pharmacists and laboratory personnel
Medical and medical sciences students
Researchers, scientists, and educators
Laboratories and pharmaceutical companies
Clinics and hospitals
Academic institutions